| Date | Time | Source | Headline | Symbol | Company |
| 03/12/2024 | 7:00AM | PR Newswire (US) | SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS | AMEX:SENS | Senseonics Holdings Inc |
| 03/08/2024 | 8:05AM | Business Wire | Senseonics Holdings, Inc. Announces Data From the Eversense® Post Approval Study to Be Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes | AMEX:SENS | Senseonics Holdings Inc |
| 03/06/2024 | 8:05AM | Business Wire | Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference | AMEX:SENS | Senseonics Holdings Inc |
| 02/29/2024 | 4:12PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SENS | Senseonics Holdings Inc |
| 02/29/2024 | 4:05PM | Business Wire | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 02/15/2024 | 4:05PM | Business Wire | Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for February 29, 2024 at 4:30 P.M. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 02/12/2024 | 7:00AM | PR Newswire (US) | MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM | AMEX:SENS | Senseonics Holdings Inc |
| 02/12/2024 | 7:00AM | Business Wire | Medicare Coverage Significantly Expanded for the Eversense E3 CGM System | AMEX:SENS | Senseonics Holdings Inc |
| 02/06/2024 | 8:00AM | Business Wire | PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care | AMEX:SENS | Senseonics Holdings Inc |
| 01/04/2024 | 4:49PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 01/04/2024 | 4:48PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 01/04/2024 | 4:48PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 01/04/2024 | 4:47PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 01/04/2024 | 4:36PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SENS | Senseonics Holdings Inc |
| 01/02/2024 | 4:05PM | Business Wire | Senseonics Holdings, Inc. Announces Business Updates | AMEX:SENS | Senseonics Holdings Inc |
| 11/17/2023 | 4:57PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 11/17/2023 | 4:56PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 11/17/2023 | 4:54PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 11/17/2023 | 4:53PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 4:27PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 4:14PM | Edgar (US Regulatory) | Form 8-K - Current report | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 4:05PM | Business Wire | Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results | AMEX:SENS | Senseonics Holdings Inc |
| 11/09/2023 | 8:05AM | Business Wire | Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference | AMEX:SENS | Senseonics Holdings Inc |
| 10/30/2023 | 4:05PM | Business Wire | Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time | AMEX:SENS | Senseonics Holdings Inc |
| 10/09/2023 | 7:00AM | Business Wire | Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes | AMEX:SENS | Senseonics Holdings Inc |
| 10/03/2023 | 4:41PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 10/03/2023 | 4:40PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 10/03/2023 | 4:39PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 10/03/2023 | 4:39PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | AMEX:SENS | Senseonics Holdings Inc |
| 09/26/2023 | 8:05AM | Business Wire | Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study | AMEX:SENS | Senseonics Holdings Inc |